FindTrial
Sign In

Ayurvedic oral medication in irregular menstruation in Poly cystic ovarian disease.

COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFECT OF KANASHATAHWADI KASHAYA GHANAVATI AND CAPSULE PCONIDD IN ARTAVKSHAYA W.S.R TO PCOD. - KANASHATAHWADI KASHAYA, PICONIDD CAP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021680
Enrollment
30
Registered
2019-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

Intervention1: Kanashatahwadi Kashaya Ghana Vati: Dose 500mg Two capsules orally thrice daily after food Duration Three months Control Intervention1: CAP PICONIDD: Dose 500mg Two capsules orally a

Sponsors

Parul Instiute of Ayurved
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Married or Unmarried women 2 Artavakshaya or Anartava for less than 3 months 3 USG showing features of PCO 4 Hyperandrogenisim

Exclusion criteria

Exclusion criteria: 1 Patient having any other disease causing Anartav and Artavkshay excluding PCOS on the above criteria 2 Patient with gross structural abnormalities of uterus and its appendages 3)Patient with any other systemic illness 4)Patient having menorrhagia or metrorrhagia

Design outcomes

Primary

MeasureTime frame
Pelvic USG showing correction in Poly cystic ovaries and ovarian volumeTimepoint: 3 months—

Secondary

MeasureTime frame
Normalcy of Menstrual cycle Correction of HyperandrogenismTimepoint: 3 months—

Countries

India

Contacts

Public ContactDr Asokan V

Parul Institue of Ayurved

drasokan24@gmail.com9008838531

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026